Envestnet Asset Management »

Tg Therapeutics shares owned by Envestnet Asset Management

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Envestnet Asset Management from 13F filings

Historical chart of Envestnet Asset Management investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Envestnet Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Envestnet Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $591k 39k 15.21
2023-09-30 $346k 41k 8.36
2023-06-30 $691k 28k 24.84
2023-03-31 $238k 16k 15.04
2022-12-31 $124k 11k 11.83
2021-09-30 $285k 8.6k 33.24
2021-06-30 $482k 12k 38.81
2021-03-31 $526k 11k 48.22
2020-12-31 $351k 6.8k 51.97

More positions owned by Envestnet Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Total Usd (IUSB)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Microsoft Corporation (MSFT)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Blackrock Etf Trust Us Eqt Factor (DYNF)
Ishares Tr S&p 500 Val Etf (IVE)

View all positions for Envestnet Asset Management

Top funds holding Tg Therapeutics

Vanguard Group
BlackRock
Millennium Management
Pictet Asset Management Holding SA
Soleus Capital Management
Wellington Management Company
Geode Capital Management
Susquehanna International
Citadel Advisors
Opaleye Management
Bank of America Corporation
Sofinnova Ventures
683 Capital Management
Nuveen Asset Management
Woodline Partners

View all funds holding Tg Therapeutics